Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 29 ... brain cells, there's evidence that having the variant is not good. But if you've got a disease that affects cognitive function, there's evidence it can act in your favor. The variant ...
2009 NOV 25 ... also suspended, earlier this year, a Phase 2 study of aplindore in Parkinson's disease. Due to the fact that at the time of suspending enrollment in that study only nine of an ...
2009 NOV 27 ... (GDNF) is a type of neurotrophic factor with significant potential in treatment of Parkinson's disease. Combining gene targeting of animal somatic cells with nuclear transfer technique has ...
2009 NOV 23 ... consistency reliability and scaling assumptions of a generic (SF-36) and Parkinson Disease (PD)-targeted (PDQ-39; PDQUALIF) health-related quality of life (HRQOL) measures. ...
2009 NOV 23 ... published in the journal Neurotoxicity Research, "Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common causes of dementia and movement disorders in the elderly. While ...
2009 NOV 23 ... According to recent research from Oporto, Portugal, "Impairment of Parkinson's disease (PD) axial motor signs (AMS) has been described as a risk factor for dementia. Executive ...
2009 NOV 23 ... (Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon. Journal of Neurology, 2009;256(10):1736-1741). For ...
2009 NOV 23 ... According to recent research from Luxembourg, "In Parkinson's disease (PD), there is entanglement of disease-inherent and treatment-induced sleep ...
2009 NOV 23 ... According to recent research published in the Journal of Proteome Research, "Parkinson's disease (PD) is characterized by loss of dopaminergic neurons in the substantia nigra and ...
2009 NOV 23 ... (Mn) toxicity in humans has been observed as manganism, a disease that resembles Parkinson's disease. The mechanism of Mn toxicity and the chemical forms that may be responsible for its ...
2009 NOV 23 ... now available. According to a study from the United States, "Although the etiology of Parkinson's disease (PD) remains elusive, a number of toxins including elevated salsolinol, an endogenous ...
2009 NOV 23 ... Keywords: City:Austin, State:TX, Country:United States, Behavior, Central Nervous System Disease, Enzymes, Metabolism, Neuroscience, Oxidase, Parkinson Disease, Stroke, University of ...
2009 NOV 23 ... Umea, Sweden, "The aim of this study was to investigate newly diagnosed patients with Parkinson's disease (PD) with structural magnetic resonance imaging (MRI), to compare them with healthy ...
2009 NOV 23 ... cognition impairments in neurological and psychiatric conditions such as Alzheimer's disease, depression and schizophrenia. Research will take place in SRI's laboratories in Menlo ...
2009 NOV 23 ... their dopaminergic neurons in the substantia nigra. The neurons lost in individuals with Parkinson's disease are dopaminergic neurons containing neuromelanin." "This raises two ...
2009 NOV 24 ... present compound in the living system and is the target in therapeutic strategy of Parkinson's disease," scientists in Madras, India report."This work reports the effect of the ...
2009 NOV 27 ... addition, TDP-43-positive inclusions are present in Parkinson disease, dementia with Lewy bodies, and 30% of Alzheimer disease cases. Pathological TDP-43 is ...
2009 NOV 23 ... to play a major role in many neurodegenerative disorders-such as multiple sclerosis, Parkinson's disease and Alzheimer's disease-only limited data exists about the role of neuroinflammation in ...
